Carnevale FC, Antunes AA, Da Motta Leal Filho JM, et al. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Cardiovasc Intervent Radiol. 2010;33(2):355–361. https://doi.org/10.1007/s00270-009-9727-z.
Demeritt JS, Elmasri FF, Esposito MP, Rosenberg GS. Relief of benign prostatic hyperplasia- transarterial polyvinyl alcohol prostate embolization 1. J Vasc Interv Radiol. 2000;11:767–70.
Article CAS PubMed Google Scholar
Uflacker A, Haskal ZJ, Bilhim T, Patrie J, Huber T, Pisco JM. Meta-analysis of prostatic artery embolization for benign prostatic hyperplasia. J Vasc Interv Radiol. 2016;27(11):1686-1697.e8. https://doi.org/10.1016/j.jvir.2016.08.004.
Jh J, Ka M, Borofsky M, et al. Jung JH, McCutcheon KA, Borofsky M, Young S, Golzarian J, Reddy B, Shin TY, Kim MH, Narayan V, Dahm P. Published online 2020. https://doi.org/10.1002/14651858.CD013656.pub2.www.cochranelibrary.com.
Malling B, Røder MA, Brasso K, Forman J, Taudorf M, Lönn L. Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Radiol. 2019;29(1):287–98. https://doi.org/10.1007/s00330-018-5564-2.
Article CAS PubMed Google Scholar
Lerner LB, McVary KT, Barry MJ, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE. Am Urol Assoc. 2021;(August):1–65. https://www.auanet.org/guidelines/guidelines/benign-prostatic-hyperplasia-(bph)-guideline.
de Assis AM, Moreira AM, de Paula Rodrigues VC, et al. Pelvic arterial anatomy relevant to prostatic artery embolisation and proposal for angiographic classification. Cardiovasc Intervent Radiol. 2015;38(4):855–61. https://doi.org/10.1007/s00270-015-1114-3.
Bilhim T, Pereira JA, Fernandes L, Tinto HR, Pisco JM. Angiographic anatomy of the male pelvic arteries. Am J Roentgenol. 2014;203(4):W373–82. https://doi.org/10.2214/AJR.13.11687.
Yoon W, Kim J, Jeon Y, Seo J, Park J, Kang K. Pelvic arterial hemorrhage in patients with pelvic fractures: detection with contrast-enhanced CT. Radiographics. 2004;24(6). https://doi.org/10.1148/rg.246045028.
Picel AC, Hsieh TC, Shapiro RM, Vezeridis AM, Isaacson AJ. Prostatic artery embolization for benign prostatic hyperplasia: patient evaluation, anatomy, and technique for successful treatment. Radiographics. 2019;39(5):1526–48. https://doi.org/10.1148/rg.2019180195.
Yamaki KI, Saga T, Doi Y, Aida K, Yoshizuka M. A statistical study of the branching of the human internal iliac artery. Kurume Med J. 1998;45(4):333–340. https://doi.org/10.2739/kurumemedj.45.333.
Zhang G, Wang M, Duan F, et al. Radiological findings of prostatic arterial anatomy for prostatic arterial embolization: preliminary study in 55 Chinese patients with benign prostatic hyperplasia. PLoS One. 2015;10(7):1–8. https://doi.org/10.1371/journal.pone.0132678.
Bilhim T, Pereira JA, Tinto HR, et al. Middle rectal artery: myth or reality? Retrospective study with CT angiography and digital subtraction angiography. Surg Radiol Anat. 2013;35(6):517–22. https://doi.org/10.1007/s00276-012-1068-y.
Martins Pisco J, Pereira J, Rio Tinto H, Fernandes L, Bilhim T. How to perform prostatic arterial embolization. Tech Vasc Interv Radiol. 2012;15(4):286–9. https://doi.org/10.1053/j.tvir.2012.09.002.
Moreira AM, de Assis AM, Carnevale FC, Antunes AA, Srougi M, Cerri GG. A review of adverse events related to prostatic artery embolization for treatment of bladder outlet obstruction due to BPH. Cardiovasc Intervent Radiol. 2017;40(10):1490–500. https://doi.org/10.1007/s00270-017-1765-3.
Isaacson AJ, Fischman AM, Burke CT. Technical feasibility of prostatic artery embolization from a transradial approach. Am J Roentgenol. 2016;206(2):442–4. https://doi.org/10.2214/AJR.15.15146.
Bhatia S, Harward SH, Sinha VK, Narayanan G. Prostate artery embolization via transradial or transulnar versus transfemoral arterial access: technical results. J Vasc Interv Radiol. 2017;28(6):898–905. https://doi.org/10.1016/j.jvir.2017.02.029.
Desai H, Yu H, Ohana E, Gunnell ET, Kim J, Isaacson A. Comparative analysis of cone-beam CT angiogram and conventional CT angiogram for prostatic artery identification prior to embolization. J Vasc Interv Radiol. 2018;29(2):229–32. https://doi.org/10.1016/j.jvir.2017.09.020.
Bagla S, Rholl KS, Sterling KM, et al. Utility of cone-beam CT imaging in prostatic artery embolization. J Vasc Interv Radiol. 2013;24(11):1603–7. https://doi.org/10.1016/j.jvir.2013.06.024.
Bagla S, Sterling KM. Pitfalls of cone beam computed tomography in prostate artery embolization. Cardiovasc Intervent Radiol. 2014;37(6):1430–5. https://doi.org/10.1007/s00270-014-0982-2.
Yu SCH, Cho C, Hung E, et al. Case-control study of intra-arterial verapamil for intraprostatic anastomoses to extraprostatic arteries in prostatic artery embolization for benign prostatic hypertrophy. J Vasc Interv Radiol. 2017;28(8):1167–76. https://doi.org/10.1016/j.jvir.2017.04.004.
Bilhim T, Pisco J, Campos Pinheiro L, et al. Does polyvinyl alcohol particle size change the outcome of prostatic arterial embolization for benign prostatic hyperplasia? Results from a single-center randomized prospective study. J Vasc Interv Radiol. 2013;24(11):1595-1602.e1. https://doi.org/10.1016/j.jvir.2013.06.003.
Gonçalves OM, Carnevale FC, Moreira AM, Antunes AA, Rodrigues VC, Srougi M. Comparative study using 100–300 versus 300–500 μm microspheres for symptomatic patients due to enlarged-BPH prostates. Cardiovasc Intervent Radiol. 2016;39(10):1372–8. https://doi.org/10.1007/s00270-016-1443-x.
Bilhim T, Pisco J, Pereira JA, et al. Predictors of clinical outcome after prostate artery embolization with spherical and nonspherical polyvinyl alcohol particles in patients with benign prostatic hyperplasia. Radiology. 2016;281(1):289–300. https://doi.org/10.1148/radiol.2016152292.
Li Q, Duan F, Wang MQ, Zhang GD, Yuan K. Prostatic arterial embolization with small sized particles for the treatment of lower urinary tract symptoms due to large benign prostatic hyperplasia: preliminary results. Chin Med J (Engl). 2015;128(15):2072–7. https://doi.org/10.4103/0366-6999.161370.
Wang MQ, Zhang JL, Xin HN, et al. Comparison of clinical outcomes of prostatic artery embolization with 50-μm plus 100-μm polyvinyl alcohol (PVA) particles versus 100-μm PVA particles alone: a prospective randomized trial. J Vasc Interv Radiol. 2018;29(12):1694–702. https://doi.org/10.1016/j.jvir.2018.06.019.
Camara-Lopes G, Mattedi R, Antunes AA, et al. The histology of prostate tissue following prostatic artery embolization for the treatment of benign prostatic hyperplasia. Int Braz J Urol. 2013;39(2):222–7. https://doi.org/10.1590/s1677-5538.ibju.2013.02.11.
Frenk NE, Baroni RH, Carnevale FC, et al. MRI findings after prostatic artery embolization for treatment of benign hyperplasia. Am J Roentgenol. 2014;203(4):813–21. https://doi.org/10.2214/AJR.13.11692.
Kisilevzky N, Faintuch S. MRI assessment of prostatic ischaemia: best predictor of clinical success after prostatic artery embolisation for benign prostatic hyperplasia. Clin Radiol. 2016;71(9):876–82. https://doi.org/10.1016/j.crad.2016.05.003.
Article CAS PubMed Google Scholar
Pisco JM, Rio Tinto H, Campos Pinheiro L, et al. Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up. Eur Radiol. 2013;23(9):2561–72. https://doi.org/10.1007/s00330-012-2714-9.
Jh J, Ka M, Borofsky M, et al. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia (review). Cochrane Database Syst Rev. 2022;3. https://doi.org/10.1002/14651858.CD012867.pub3.www.cochranelibrary.com.
Franco J, Jung J, Imamura M, et al. Minimally invasive treatments for lower urinary tract symptoms inmen with benign prostatic hyperplasia: a network meta-analysis(review). Cochrane Database Syst Rev. 2021;2021(12).
Zumstein V, Betschart P, Vetterlein MW, et al. Prostatic artery embolization versus standard surgical treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Urol Focus. 2019;5(6):1091–100. https://doi.org/10.1016/j.euf.2018.09.005.
Jiang Y-L, Qian L-J. Transurethral resection of the prostate versus prostatic artery embolization in the treatment of benign prostatic hyperplasia: a meta-analysis. BMC Urol. 2019;19(11).
Fu Y, Wen X, Yin Y, Wang C, Mai J. Comparison of effectiveness and postoperative complications of different surgical methods in the treatment of benign prostatic hyperplasia: a systematic review and meta-analysis based on randomized controlled trials. Transl Androl Urol. 2022;11(6):842–58. https://doi.org/10.21037/tau-22-377.
Article PubMed PubMed Central Google Scholar
•• Knight GM, Talwar A, Salem R, Mouli S. Systematic review and meta-analysis comparing prostatic artery embolization to gold-standard transurethral resection of the prostate for benign prostatic hyperplasia. Cardiovasc Intervent Radiol. 2021;44(2):183–93. https://doi.org/10.1007/s00270-020-02657-5. Interesting meta-analysis in which PAE was equally efficacious when compared to gold standard TURP in terms of improvement in both objective and subjective categories including IPSS, IPSS-QoL, IIEF-5, and PVR while having a significantly shorter hospital length of stay and fewer adverse events.
Abt D, Hechelhammer L, Müllhaupt G, et al. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial. BMJ. 2018;361. https://doi.org/10.1136/bmj.k2338.
Ray AF, Powell J, Speakman MJ, et al. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study). BJU Int. 2018;122(2):270–82. https://doi.org/10.1111/bju.14249.
•• LaRussa S, Pantuck M, Wilcox Vanden Berg R, Gaffney CD, Askin G, McClure T. Symptomatic improvement of lower urinary tract symptoms of benign prostatic hyperplasia: a comparative systematic review and meta-analysis of 4 different minimally invasive therapies. J Vasc Interv Radiol. 2021;32(9):1328–1340.e11. https://doi.org/10.1016/j.jvir.2021.06.019. Unique article comparing multiple minimally invasive techniques including prostatic artery embolization (PAE), photoselective vaporization (PVP), prostatic urethral lift (PUL), and water vapor thermal therapy (WV). PAE performed significantly better than PUL and WV in IPSS and QOL after 6 months, and was the only modality that showed continued improvement in these measures between 6 and 12 months. Only PAE resulted in improved IIEF.
Costa NV, Torres D, Pisco J, et al. Repeat prostatic artery embolization for patients with benign prostatic hyperplasia. J Vasc Interv Radiol. 2020;31(8):1272–80. https://doi.org/10.1016/j.jvir.2020.04.027.
Gao YA, Huang Y, Zhang R, et al. Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate-a prospective, randomized, and controlled clinical trial. Radiology. 2014;270(3):920–8. https://doi.org/10.1148/radiol.13122803.
Alrashidi I, Alahmari F, Garad F, et al. Intraprostatic abscess: an acute complication of prostatic artery embolization. J Vasc Interv Radiol. 2019;30(2):267–9. https://doi.org/10.1016/j.jvir.2018.11.024.
Kisilevzky N, Laudanna Neto C, Cividanes A. Ischemia of the glans penis following prostatic artery embolization. J Vasc Interv Radiol. 2016;27(11):1745–7. https://doi.org/10.1016/j.jvir.2016.06.017.
Laborda A, De Assis AM, Ioakeim I, Sánchez-Ballestín M, Carnevale FC, De Gregorio MA. Radiodermitis after prostatic artery embolization: case report and review of the literature. Cardiovasc Intervent Radiol. 2015;38(3):755–9. https://doi.org/10.1007/s00270-015-1083-6.
Comments (0)